Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 7, 2015; 21(5): 1498-1509
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1498
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1498
Figure 8 Vincristine at 0.
1 μmol/L does not cause significant cell apoptosis. HepG2.2.15 (4 × 105/well) and HepG2-HBV1.1 (6 × 105/well) cells were treated with vincristine at a concentration of 0.1 μmol/L for 24 h, followed by 48 h of incubation in drug-free culture medium. A: The level of apoptosis in the HepG2.2.15 cells was detected based on flow cytometry; B: The level of apoptosis in the HepG2-HBV1.1 cells was detected based on flow cytometry; C: Western blot analysis of the PARP protein. PARP: Poly(ADP-ribose) polymerase; LR: Lower-right; UR: Upper-right.
- Citation: Xu L, Tu Z, Xu G, Hu JL, Cai XF, Zhan XX, Wang YW, Huang Y, Chen J, Huang AL. S-phase arrest after vincristine treatment may promote hepatitis B virus replication. World J Gastroenterol 2015; 21(5): 1498-1509
- URL: https://www.wjgnet.com/1007-9327/full/v21/i5/1498.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i5.1498